IXENDI Trademark

Trademark Overview

On Tuesday, September 20, 2011, a trademark application was filed for IXENDI with the United States Patent and Trademark Office. The USPTO has given the IXENDI trademark a serial number of 85426956. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 4, 2015. This trademark is owned by Glaxo Group Limited. The IXENDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ixendi

General Information

Serial Number85426956
Word MarkIXENDI
Filing DateTuesday, September 20, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 4, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 23, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, May 4, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 4, 2015ABANDONMENT - NO USE STATEMENT FILED
Friday, October 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 2, 2014EXTENSION 5 GRANTED
Tuesday, September 30, 2014EXTENSION 5 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 7, 2014EXTENSION 4 GRANTED
Saturday, March 1, 2014EXTENSION 4 FILED
Monday, March 31, 2014TEAS EXTENSION RECEIVED
Wednesday, September 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2013EXTENSION 3 GRANTED
Wednesday, September 18, 2013EXTENSION 3 FILED
Wednesday, September 18, 2013TEAS EXTENSION RECEIVED
Thursday, April 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 17, 2013EXTENSION 2 GRANTED
Wednesday, March 27, 2013EXTENSION 2 FILED
Wednesday, April 17, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 27, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 21, 2012EXTENSION 1 GRANTED
Wednesday, September 19, 2012EXTENSION 1 FILED
Thursday, September 20, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 19, 2012TEAS EXTENSION RECEIVED
Tuesday, April 3, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2012PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 5, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 5, 2012ASSIGNED TO LIE
Wednesday, December 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2011ASSIGNED TO EXAMINER
Friday, September 23, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 23, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

ixendi pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological